Literature DB >> 1993624

A review of hypoxic cell radiosensitization.

S Dische1.   

Abstract

Despite an enormous laboratory and clinical effort, advance in patient care has not yet been achieved by hypoxic cell radiosensitization. The reasons for this are considered and suggestions made as to the future direction of work in this important field.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993624     DOI: 10.1016/0360-3016(91)90151-s

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

Review 1.  Nitroimidazoles as hypoxic cell radiosensitizers and hypoxia probes: misonidazole, myths and mistakes.

Authors:  Peter Wardman
Journal:  Br J Radiol       Date:  2018-03-20       Impact factor: 3.039

2.  Noninvasive assessment of tumor hypoxia with 99mTc labeled metronidazole.

Authors:  D J Yang; S Ilgan; T Higuchi; F Zareneyrizi; C S Oh; C W Liu; E E Kim; D A Podoloff
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

Review 3.  Current perspectives in gliomas.

Authors:  C S Brock; M Bower
Journal:  Med Oncol       Date:  1997-06       Impact factor: 3.738

4.  Enhancement of the cytotoxicity of SR 4233 to normal and malignant tissues by hypoxic breathing.

Authors:  A I Minchinton; J M Brown
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

5.  Comparison of in vivo efficacy of hypoxic cytotoxin tirapazamine and hypoxic cell radiosensitizer KU-2285 in combination with single and fractionated irradiation.

Authors:  T Shibata; Y Shibamoto; K Sasai; N Oya; R Murata; T Takagi; M Hiraoka; M Abe
Journal:  Jpn J Cancer Res       Date:  1996-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.